Uterine sarcomas: A review, Gynecologic Oncology, vol.116, issue.1, pp.131-140, 2010. ,
DOI : 10.1016/j.ygyno.2009.09.023
Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium, International Journal of Gynecology & Obstetrics, vol.105, issue.2, pp.103-107, 2009. ,
DOI : 10.1016/j.ijgo.2009.02.012
Rare uterine cancer: Carcinosarcomas. Review from histology to treatment, Critical Reviews in Oncology/Hematology, vol.94, issue.1, pp.98-104, 2010. ,
DOI : 10.1016/j.critrevonc.2014.10.013
Léiomyosarcomes utérins : épidémiologie, histologie, biologie, diagnostic, pronostic et traitement, Bulletin du cancer. sept, pp.903-918, 2013. ,
Prognostic factors in early-stage uterine sarcoma: A gynecologic oncology group study, Cancer, vol.34, issue.S4, 1993. ,
DOI : 10.1002/cncr.2820710440
Staging of uterine sarcomas, Best Practice & Research Clinical Obstetrics & Gynaecology, vol.25, issue.6, pp.733-782, 2011. ,
DOI : 10.1016/j.bpobgyn.2011.05.011
Endometrial Stromal Sarcomas and Related High-grade Sarcomas: Immunohistochemical and Molecular Genetic Study of 31 Cases, The American Journal of Surgical Pathology, vol.32, issue.8, pp.1228-1266, 2008. ,
DOI : 10.1097/PAS.0b013e31816a3b42
Molecular Analysis of the JAZF1-JJAZ1 Gene Fusion by RT-PCR and Fluorescence In Situ Hybridization in Endometrial Stromal Neoplasms, The American Journal of Surgical Pathology, vol.31, issue.1, pp.65-70, 2007. ,
DOI : 10.1097/01.pas.0000213327.86992.d1
Frequency of Known Gene Rearrangements in Endometrial Stromal Tumors, The American Journal of Surgical Pathology, vol.35, issue.9, pp.1364-72, 2011. ,
DOI : 10.1097/PAS.0b013e3182262743
Gynecologic Cancer InterGroup (GCIG) Consensus Review for High-Grade Undifferentiated Sarcomas of the Uterus, International Journal of Gynecological Cancer, vol.24, issue.9, pp.73-77, 2014. ,
DOI : 10.1097/IGC.0000000000000281
Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma, Cancer. 15 mars, vol.88, issue.6, pp.1425-1456, 2000. ,
Prognostic Factors in Early-Stage Leiomyosarcoma of the Uterus, International Journal of Gynecological Cancer, vol.62, issue.3, pp.385-90, 2009. ,
DOI : 10.1111/IGC.0b013e3181a1bfbc
p53 protein overexpression in smooth muscle tumors of the uterus*1, Human Pathology, vol.26, issue.4, pp.375-384, 1995. ,
DOI : 10.1016/0046-8177(95)90136-1
Analysis of Ki-ras, p53, and MDM2 Genes in Uterine Leiomyomas and Leiomyosarcomas, Gynecologic Oncology, vol.65, issue.2, pp.330-335, 1997. ,
DOI : 10.1006/gyno.1997.4653
Leiomyosarcoma of the Uterus: A Clinicopathologic, DNA Flow Cytometric, p53, and mdm-2 Analysis of 49 Cases, Gynecologic Oncology, vol.68, issue.1, pp.54-61, 1998. ,
DOI : 10.1006/gyno.1997.4889
The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study, Gynecologic Oncology, vol.99, issue.1, pp.36-42, 2005. ,
DOI : 10.1016/j.ygyno.2005.05.019
Uterine leiomyosarcomas: Tumor size, mitotic index, and biomarkers Ki67, and Bcl-2 identify two groups with different prognosis, Gynecologic Oncology, vol.121, issue.2, pp.328-361, 2011. ,
DOI : 10.1016/j.ygyno.2011.01.022
Clinical management of uterine sarcomas, The Lancet Oncology, vol.10, issue.12, pp.1188-98, 2009. ,
DOI : 10.1016/S1470-2045(09)70226-8
A nomogram to predict postresection 5-year overall survival for patients with uterine leiomyosarcoma, Cancer, vol.101, issue.suppl 1, pp.660-669, 2012. ,
DOI : 10.1002/cncr.26333
External validation of a prognostic nomogram for overall survival in women with uterine leiomyosarcoma, Cancer, vol.78, issue.10, pp.1816-1838, 2013. ,
DOI : 10.1002/cncr.27971
Endometrial Stromal Sarcomas, Advances in Anatomic Pathology, vol.17, issue.2, pp.113-134, 2010. ,
DOI : 10.1097/PAP.0b013e3181cfb7c2
Surgery for uterine sarcoma: review of the literature and recommendations for the standard surgical procedure]. Gynécologie Obstétrique Fertil, févr, vol.31, issue.2, pp.147-50, 2003. ,
Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy???, Gynecologic Oncology, vol.89, issue.3, pp.460-469, 2003. ,
DOI : 10.1016/S0090-8258(03)00137-9
Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus, Gynecologic Oncology, vol.91, issue.1, pp.209-221, 2003. ,
DOI : 10.1016/S0090-8258(03)00478-5
Uterine Leiomyosarcoma and Endometrial Stromal Sarcoma: Lymph Node Metastases and Sites of Recurrence, Gynecologic Oncology, vol.50, issue.1, pp.105-114, 1993. ,
DOI : 10.1006/gyno.1993.1172
Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas, Cancer, vol.92, issue.4, pp.820-850, 2008. ,
DOI : 10.1002/cncr.23245
Endometrial stromal sarcoma: a population-based analysis, British Journal of Cancer, vol.106, issue.8, pp.1210-1215, 2008. ,
DOI : 10.3322/canjclin.46.2.113
Lymphadenectomy and Ovarian Preservation in Low-Grade Endometrial Stromal Sarcoma, Obstetrics & Gynecology, vol.112, issue.5, pp.1102-1110, 2008. ,
DOI : 10.1097/AOG.0b013e31818aa89a
Stage IA vs. IB endometrial stromal sarcoma: Does the new staging system predict survival?, Gynecologic Oncology, vol.118, issue.1, pp.8-13, 2010. ,
DOI : 10.1016/j.ygyno.2010.04.008
Lymph node metastases in low-grade endometrial stromal sarcoma, Gynecologic Oncology, vol.96, issue.2, pp.402-408, 2005. ,
DOI : 10.1016/j.ygyno.2004.10.021
Does Radiotherapy or Lymphadenectomy Improve Survival in Endometrial Stromal Sarcoma?, International Journal of Gynecological Cancer, vol.50, issue.7, pp.1232-1240, 2009. ,
DOI : 10.1111/IGC.0b013e3181b33c9a
Should lymphadenectomy be performed in patients with endometrial stromal sarcoma?, Gynecologic Oncology, vol.97, issue.3, pp.982-982, 2005. ,
DOI : 10.1016/j.ygyno.2005.01.034
The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma, Gynecologic Oncology, vol.122, issue.2, pp.255-264, 2011. ,
DOI : 10.1016/j.ygyno.2011.04.021
The Role of Adjuvant Radiation in Uterine Sarcomas, International Journal of Radiation Oncology*Biology*Physics, vol.76, issue.3, pp.728-762, 2010. ,
DOI : 10.1016/j.ijrobp.2009.02.077
Uterine Leiomyosarcoma: Analysis of Treatment Failures and Survival, Gynecologic Oncology, vol.62, issue.1, pp.25-32, 1996. ,
DOI : 10.1006/gyno.1996.0185
Endometrial Stromal Sarcoma: Analysis of Treatment Failures and Survival, Gynecologic Oncology, vol.63, issue.2, pp.247-53, 1996. ,
DOI : 10.1006/gyno.1996.0314
A multi-institutional review of outcomes of endometrial stromal sarcoma, Gynecologic Oncology, vol.105, issue.3, pp.630-634, 2007. ,
DOI : 10.1016/j.ygyno.2007.01.031
Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874), European Journal of Cancer, vol.44, issue.6, pp.808-826, 1990. ,
DOI : 10.1016/j.ejca.2008.01.019
A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I???IV carcinosarcoma (CS) of the uterus???, Gynecologic Oncology, vol.107, issue.2, pp.177-85, 2007. ,
DOI : 10.1016/j.ygyno.2007.07.070
Role of radiotherapy treatment of uterine sarcoma, Best Practice & Research Clinical Obstetrics & Gynaecology, vol.25, issue.6, pp.761-72, 2011. ,
DOI : 10.1016/j.bpobgyn.2011.06.004
Consensus Guidelines for Delineation of Clinical Target Volume for Intensity-Modulated Pelvic Radiotherapy in Postoperative Treatment of Endometrial and Cervical Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.71, issue.2, pp.428-462, 2008. ,
DOI : 10.1016/j.ijrobp.2007.09.042
A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study., Journal of Clinical Oncology, vol.3, issue.9, pp.1240-1245, 1985. ,
DOI : 10.1200/JCO.1985.3.9.1240
A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group, Annals of Oncology, vol.24, issue.4, pp.1099-104, 2013. ,
DOI : 10.1093/annonc/mds545
A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas, Cancer, vol.3, issue.4, pp.626-658, 1983. ,
DOI : 10.1002/1097-0142(19830815)52:4<626::AID-CNCR2820520409>3.0.CO;2-E
Ifosfamide and Doxorubicin in the Treatment of Advanced Leiomyosarcomas of the Uterus: A Gynecologic Oncology Group Study, Gynecologic Oncology, vol.62, issue.2, pp.226-235, 1996. ,
DOI : 10.1006/gyno.1996.0220
Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II trial, Gynecologic Oncology, vol.109, issue.3, pp.329-363, 2008. ,
DOI : 10.1016/j.ygyno.2008.03.010
A phase II evaluation of trabectedin in the treatment of advanced, persistent, or recurrent uterine leiomyosarcoma: A gynecologic oncology group study, Gynecologic Oncology, vol.124, issue.1, pp.48-52, 2012. ,
DOI : 10.1016/j.ygyno.2011.09.019
Randomized Multicenter and Stratified Phase II Study of Gemcitabine Alone Versus Gemcitabine and Docetaxel in Patients with Metastatic or Relapsed Leiomyosarcomas: A Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study), The Oncologist, vol.17, issue.9, pp.1213-1233, 2012. ,
DOI : 10.1634/theoncologist.2011-0467
Treatment of advanced uterine leiomyosarcoma with aromatase inhibitors, Gynecologic Oncology, vol.116, issue.3, pp.424-433, 2010. ,
DOI : 10.1016/j.ygyno.2009.10.064
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial, The Lancet, vol.379, issue.9829, pp.1879-86, 2012. ,
DOI : 10.1016/S0140-6736(12)60651-5
Surgical Resection of Pulmonary and Extrapulmonary Recurrences of Uterine Leiomyosarcoma, Gynecologic Oncology, vol.87, issue.3, pp.287-94, 2002. ,
DOI : 10.1006/gyno.2002.6840
Factors affecting the outcome of patients with metastatic leiomyosarcoma treated with doxorubicin-containing chemotherapy, Annals of Oncology, vol.21, issue.6, pp.1361-1366, 2010. ,
DOI : 10.1093/annonc/mdp485
Impact of radiotherapy on local control and survival in uterine sarcomas: a retrospective study from the GRUP ONCOLOGIC CATAL??-OCCIT??, International Journal of Radiation Oncology*Biology*Physics, vol.44, issue.1, pp.47-52, 1999. ,
DOI : 10.1016/S0360-3016(98)00515-X
Stage-Specific Outcomes of Patients With Uterine Leiomyosarcoma: A Comparison of the International Federation of Gynecology and Obstetrics and American Joint Committee on Cancer Staging Systems, Journal of Clinical Oncology, vol.27, issue.12, pp.2066-72, 2009. ,
DOI : 10.1200/JCO.2008.19.8366
FIGO staging for uterine sarcomas, International Journal of Gynecology & Obstetrics, vol.112, issue.(4), pp.177-185, 2009. ,
DOI : 10.1016/j.ijgo.2008.12.008
History of the FIGO cancer staging system, International Journal of Gynecology & Obstetrics, vol.6, issue.(Suppl l), pp.205-215, 2008. ,
DOI : 10.1016/j.ijgo.2007.11.004
Validation of Tumor Size as Staging Variable in the Revised International Federation of Gynecology and Obstetrics Stage I Leiomyosarcoma, International Journal of Gynecological Cancer, vol.280, issue.7, pp.1201-1207, 2010. ,
DOI : 10.1111/IGC.0b013e3181e9d0ba
The Role of Whole-Pelvic Irradiation in the Treatment of Early-Stage Uterine Carcinosarcoma, Gynecologic Oncology, vol.65, issue.3, pp.493-501, 1997. ,
DOI : 10.1006/gyno.1997.4676